Overview and Registration Fees

There are ongoing significant advances in transfusion medicine and science with high quality research supporting evidence-based practice. This two day meeting organised on behalf of the Royal College of Pathologists brings together experts from various clinical disciplines together with leaders in transfusion science to provide a broad overview of current key developments. The meeting will be of wide interest to all those involved in transfusion medicine.

We are also inviting submission of abstracts by young investigators (medical trainees, scientists and transfusion practitioners) with best abstracts accepted for either oral or poster presentation at the symposium.  Please see further details under above 'Abstracts' tab

 

Registration Fees

Two-day registration fees apply only. 

Registration is for both days but you can share this with a colleague so each attends one day.  One delegates should make the online payment and then email us to inform the name and contact email of the second attendee and which day they are attending

Two day fees 
RCPath Fellows £370
Concessions £190 (Trainees, BMS, Nurses, Retired)
Non-members £425

 

 

 

Programme

Thursday 22nd November 2018

10:00     Registration and coffee

10:30     Welcome - Professor Jo Martin, President, Royal College of Pathologists

 Chair: Professor David Roberts, NHSBT

10:40     Keynote speaker - Professor Meghan Delaney, The George Washington University, Washington, USA

Evidence based transfusion practice: Chair – Dr Shubha Allard, Barts Health NHS Trust & NHSBT

11:20     International NAIT guideline - Professor Lani Lieberman, University of Toronto, Canada

11:45     Near patient haemostasis testing - challenges to implementation - Dr Jecko Thachil, Manchester University NHS Foundation Trust

12:10     Advances in Sickle cell Disease - Dr Jo Howard, Guy’s & St Thomas’ NHS Foundation Trust, London

12:35     Discussion

12.50     Percy Oliver Award for Achievements in Transfusion Medicine/Science

13.00     Lunch

Advances in transfusion science: Chair - Professor Mike Murphy, John Radcliffe Hospital & NHSBT

14:00     TTP and advances - Professor Marie Scully, University College London

14:25     INTERVAL Trial – genetic testing- Dr Adam Butterworth, University of Cambridge

14:50     Organ transplantation – achievements & challenges - John Forsythe, Medical Director Organ Donation & Transplant, NHSBT

15:15     COFFEE

15:45     Tranexamic acid for all - Professor Beverley Hunt, Guy’s & St Thomas’ NHS Foundation Trust, London

16:10     Young investigator – 2 talks of 10 minutes each based on best abstract selection

16.30     Close

 

Viewing of posters elected as best abstracts will take place over lunch & coffee

 

 

Friday 23rd November 2018

 

09:00     Coffee

Transfusion safety: Chair - Professor Lorna Williamson, Royal College of Pathologists

09:30     21 years old - SHOT comes of age - Dr Paula Bolton-Maggs, Medical Director, Serious Hazards of Transfusion

09:55     Blood Safety – learning from the past and looking to the future - Dr Ines Ushiro-Lumb, NHSBT and PHE

10:20     Horizon seeking - new components - Dr Rebecca Cardigan, Head of Components Development, NHSBT

10:45     Discussion

10:55     Coffee

 Clinical practice: Chair - Dr Megan Rowley, Scottish National Blood Transfusion Service

11:25     Aplastic Anaemia - Professor Judith Marsh, Kings College Hospital, London

11.50     Platelets - trials & guidelines - Dr Lise Estcourt, University of Oxford and NHSBT

12:15     Haemato oncology & transfusion - practical challenges - Dr Jonathan Wallis, Newcastle upon Tyne Hospitals NHS Foundation Trust

12:50     Discussion

13:00     LUNCH

Improving the impact of PBM: Chair - Dr Janet Birchall, Welsh Blood Service

14:00     Pre-op anaemia – how do we change practice? - Dr Alwyn Kotze, Leeds Teaching Hospitals NHS Trust

14:25     Patient Blood Management and Paediatrics - Professor Meghan Delaney

14:50     International Patient Blood Management Consensus conference - a summary- Dr Cynthia So-Osman, Sanquin, Netherlands

15:30     Close

Abstracts

Abstract Guidelines

Presentations

Two authors will be selected to give an oral presentation about their work. Each author will receive free meeting registration for the 22nd and 23rd November, free travel, and free overnight accommodation.

Posters

Ten authors will be selected to present a poster on the 22nd November. All poster authors will receive free meeting registration for the 22nd November. The best poster will receive a Wiley book prize.

 

All abstracts presented at the conference will be published in Transfusion Medicine.

IMPORTANT DATES

  • Abstract submission opens: 30th March 2018
  • Abstract submission closes: 14th September 2018
  • Abstract notification: Week commencing 22nd October 2018

Abstracts received after the deadline will not be accepted.

 

DEFINITIONS

  • Submitting author: person who physically submits the abstract
  • Presenting author: person who will physically present the abstract at the conference and who is marked as the presenter in the program.
  • First author: First author cited who scientifically endorses the abstract and is therefore responsible for its conten

 

  1. Abstracts must be related to transfusion medicine.
  2. Abstracts can present results from research, audit, quality improvement, original small studies, or systematic reviews
  3. Abstracts submitted should be previously unpublished data
  4. The presenting author must be a doctor-in-training, transfusion practitioner, or laboratory scientist.
  5. Abbreviations should be defined.
  6. The abstract must contain a maximum of 300 words.
  7. The abstract must contain results, otherwise the abstracts will be unhelpful to future readers.
  8. When you submit an abstract for the first time you will be given a unique Reference Number. Please make a note of this so that, if required, you can recall and update/amend your submission. Abstracts can be amended up to midnight on 1st July 2018.
  9. Please ensure that your abstract does not contain spelling, grammatical or scientific errors. No corrections are possible after the submission deadline. The abstract will be reproduced exactly as submitted in the event materials. No proofreading will be done of the scientific content.
  10. If you need to withdraw your abstract, a written statement reflecting the reasons for this decision must be sent to meetings@rcpath.org, no later than 15 July 2018.

AFTER THE SUBMISSION

  1. The Programme Committee reserve the right of final decisions regarding acceptance of abstracts and the form of presentation.
  2. The submitting authors will be notified in the week beginning the 3rd September 2018, at the email address provided during submission, whether their abstract has been accepted. It is the author’s responsibility to ensure that emails can reach them. They will be informed at the same time about the date, time and format of their presentation.

PRESENTATION OF ABSTRACTS

  1. Abstracts can be accepted either as a poster or oral presentation. Oral presentations will be advised of presentation time and length of presentation once abstract has been accepted.
  2. If your abstract is accepted as a poster, you will be requested to be available for discussion during the poster viewing session on 22nd November 2018. Please use letters large enough to be read from a distance of 1.5 meters (4.9 feet).
  3. Full presentation guidelines will be included in the acceptance letter and posted on the conference website.

ABSTRACT TYPING INSTRUCTIONS

  1. Maximum word count is 300 words (excluding title, author list and affiliations).
  2. Formatting your abstract Please use International characters only.
  3. Please type in "Normal sentence case", not all in CAPITALS.
  4. Make the title intelligible to all. Abbreviations should not be used in the title.
  5. List all authors and affiliations. Highlight presenting author with an *.
  6. Reduce abbreviations to a minimum, especially non-standard ones, and define at first use.
  7. Use only use normal keyboard characters.
  8. All abstracts will be reproduced exactly as submitted so please check the text for typing errors before you submit.
  9. Please state within the submission e-mail whether the presenting author is a doctor-in-training, transfusion practitioner, or laboratory scientist.
  10. Please submit the abstract to meetings@rcpath.org

DISCLOSURES

Authors are responsible for reporting any real or perceived financial conflict of interest. A brief disclosure and conflict of interest statement should be included in the submitted abstract and viewable on the poster. Any potential for financial gain that may be derived from reported work may constitute a possible conflict of interest. Disclosure is required in any case in which an individual or company stands to benefit financially from research performed. Therefore, each author must indicate any benefit to an individual or company that may potentially lead to financial reward.

Disclosures should appear on the bottom left corner of the poster and may follow the recommended format: "Disclosures: None" or "Disclosures: The author/s (insert preferred abbreviation) disclose a relationship with..."

 

Speakers

Speakers

  • Professor Meghan Delaney

    Meghan Delaney received a doctor of medicine degree from the University of New England College of Osteopathic Medicine in Biddeford, Maine, and a master of public health degree from the University of Washington School of Public Health in Seattle. Dr Delaney is the Chief of Pathology & Laboratory Medicine at Children’s National Health System based in Washington, DC; the only free-standing health care system designed for kids in the nation.  The Division performs vital diagnostic testing and interpretation services for all divisions at Children’s National Health System, including Children’s regional outpatient centers, and mobile health units in the greater Washington, DC, area.  

  • Professor Beverley Hunt

    Professor of Thrombosis & Haemostasis at King’s College London;

    Consultant in the Departments of Haematology & Pathology at Guy’s & St Thomas NHS Foundation Trust; & Clinical Lead in Haematological Sciences at Viapath LLP

    Clinical & laboratory

    Professor Hunt has a large clinical practice, specialising in thrombosis and haemostasis & obstetric haematology. She leads on the management of VTE within GSTT. She set up the award-winning “Thrombosis” app – thrombosis management in elegant algorithms. Her laboratory work includes sitting on the board of Viapath LLP and leading in all aspects of haematological laboratory work.

     

  • Dr Jecko Thachil

    Dr Thachil is a Consultant Haematologist at the Manchester Royal Infirmary working as a specialist who deals with bleeding and clotting problems in various specialities. His research work focused on the role of platelets interaction with white cells in inflammation and sepsis. Dr Thachil has published over 250 peer-reviewed papers, serve as reviewer for 25 journals and edited the popular books; Haematology in Critical Care and Handbook of Venous Thromboembolism and written several book chapters.

  • Professor Mike Murphy

    Mike Murphy is Professor of Transfusion Medicine at the University of Oxford and Consultant Haematologist for NHS Blood & Transplant and Oxford University Hospitals. He qualified at St.Bartholomew’s Hospital Medical College, University of London, where he completed his training in haematology and became a Senior Lecturer in Haematology. In 1996, he moved to Oxford.

    He is a recipient of the British Blood Transfusion Society's Kenneth Goldsmith Award, and co-founded the NHSBT Clinical Studies Unit, its Systematic Reviews Initiative for transfusion medicine and the Transfusion Evidence Library (www.transfusionevidencelibrary.com). His work using technology to improve transfusion practice has won numerous national awards and is an exemplar for the NHS Quality, Innovation, Prevention and Productivity (QIPP) initiative.

     

  • Professor Lorna Williamson

    Lorna Williamson was Reader and Honorary Consultant in Transfusion Medicine in the University of Cambridge for nearly 20 years, undertaking clinical research, including randomised trials.  She was NHS Blood and Transplant’s Medical and Research Director from 2007 till 2016, and has held many roles advising on national and international transfusion policy and safety. Following her retirement from the NHS, she has developed an interest in communicating science to the public.  Her current passions are female education through her support for CamFed, helping women in medicine and science, and the fortunes of the Scottish rugby teams, both female and male.

  • Dr Paula Bolton-Maggs

    Paula trained at both Cambridge and Oxford Universities and has been a consultant haematologist for 27 years, initially as a paediatric haematologist at Alder Hey Children’s Hospital in Liverpool and then as a consultant in adult haemostasis and thrombosis at Manchester Royal Infirmary.

    In 2011 she took up her current appointment as Medical Director of the UK national haemovigilance scheme, Serious Hazards of Transfusion (www.shotuk.org). Her main research areas have been Factor XI deficiency and immune thrombocytopenia.  She has had a longstanding interest in both haemostasis and transfusion and has contributed to several national British Society for Haematology guidelines and their recent updates (including paediatric transfusion, the administration of blood components and appropriate use of FFP and cryoprecipitate) in addition to the updated guidelines on irradiation of blood components.  She has published more than 150 peer-reviewed papers and guidelines and is an honorary senior lecturer at the University of Manchester.

  • Dr Ines Ushiro-Lumb

    After a decade as a Consultant Virologist at Barts Health Trust, Inês joined NHS Blood and Transplant in 2012 and is the Lead Clinical Microbiologist for Organ Donation and Transplantation and Clinical Director of the National Transfusion Microbiology Reference Laboratory; she is also a Consultant Virologist at Public Health England. Inês is a member of the UK Standing Advisory Committee on Transfusion-Transmitted Infections and the ISBT Transfusion-Transmitted Infectious Diseases Working Party.

     Previous areas of activity in Clinical Microbiology include foetal, paediatric, and blood-borne infections, outbreak investigations, infections in the immunocompromised host and evaluation of diagnostic assays for use in resource-limited settings.

  • Dr Rebecca Cardigan

    Rebecca Cardigan is a Clinical Scientist working in Haematology since 1992, firstly at University College London in Haemostasis and then NHS Blood & Transplant. She is currently Head of Components Development for NHSBT, Deputy Director of the UK Joint Professional Advisory Committee and Affiliated Lecturer, Department of Haematology, University of Cambridge.  Her main areas of scientific interest relate to the laboratory and clinical evaluation of major changes to blood component production and methods used to assess blood component quality.

  • Professor Judith Marsh

    Judith Marsh is Professor of Clinical Haematology and ConsuItant Haematologist at King’s College Hospital/King’s College London. Prof Marsh leads the clinical and academic Bone Marrow Failure Unit at King's College Hospital, London. Prof Marsh chairs the British Committee for Standards in Haematology (BCSH) writing committee of the national aplastic anaemia guidelines. She is a member of the medical advisory board for the AA&MDS International Foundation, USA. Prof Marsh is a past chair of the EBMT Severe Aplastic Anaemia Working Party, and the CIBMTR Non-malignant Marrow Disorders Working Committee, and is a member of the American Society of Hematology (ASH) Scientific Committee on Bone Marrow Failure.

  • Dr Janet Birchall

    Dr Birchall has been a Consultant Haematologist for 15 years mostly working in a large teaching hospital and supporting the implementation of Patient Blood Management at a local, regional and national level. She has contributed to systematic review to assess the evidence, British Society of Haematology guidelines to direct practice, the National Blood Transfusion Committee indication codes (including an app) to make guidance available at the bedside and lead national audit to monitor performance. Dr Birchall understands the huge effort involved in setting and delivering standards and the difficulties of implementation at a hospital level.

  • Dr Cynthia So-Osman

    Dr Cynthia So-Osman followed a specialisation in Internal Medicine, with a subspecialty training in Haematology (2000) and in Transfusion Medicine (2002). She obtained a Master of Science (MSc) degree in Clinical Epidemiology (2008) and obtained her PhD with a thesis titled: “ Patient Blood Management in Elective Orthopaedic Surgery” in 2012. Since 2002 she is a Clinical Consultant in Transfusion Medicine at Sanquin Blood Supply at the Dept. of Transfusion Medicine and she actively participates in Patient Blood Management studies at the Centre of Clinical Transfusion Research in Leiden.

     

 

Location

To be held at the Royal College of Pathologists, 6 Alie Street, London, E1 8QT